V
ERTEBRAL artery (VA) end-to-side transposition to the common carotid artery (CCA) in order to relieve symptoms of hindbrain ischemia due to proximal VA disease or subclavian steal syndrome has been reported by several authors with good results.a- 4,6,8-m,15,17 It may be technically difficult to obtain adequate lengths of VA to transpose to the CCA, depending on anatomical variations and the extent of the diseased portion of the VA. This report discusses the long-term follow-up results in eight patients undergoing a VA-CCA transposition when an interposition graft of polytetrafluoroethylene (PTFE) 2 cm in length and 3 or 4 mm in diameter was used.* Earlier results have been published previously. ~7
Clinical Material and Methods
Twenty VA-CCA transpositions were performed by the neurosurgical service at the University of Texas * Gore-tex tubing obtained from W. L. Gore & Associates, Flagstaff, Arizona.
Health Science Center, San Antonio, between January, 1978, and December, 1982. An interposition graft was deemed necessary in 11 patients: saphenous vein was used in three cases, and a PTFE graft in eight. The diameter of the PTFE graft was 3 or 4 mm, depending on the size of the VA. The purpose of this paper is to present the long-term follow-up findings in the eight patients with PTFE interposition grafts.
Follow-up results were obtained for all of the patients receiving PTFE interposition grafts. The characteristics of this group did not differ significantly from the remainder of the series. The average age at the time of operation was 58.9 years (range 46 to 71 years) for the PTFE group and 58.3 years (range 48 to 67 years) for the group with direct anastomosis or vein interposition grafting. The PTFE placement operation involved the left VA in five cases and the right VA in three cases. Table 1 lists the procedures performed, the diameter of the interposition grafts, the clinical follow-up period, and the most recent angiographic findings. Figures 1,  2 , and 3 present angiograms taken from patients having 
Discussion
When an adequate length of a VA is not available for transposition to the CCA, operative choices include further dissection of the artery from the transverse foramina or interposition of a graft. Further dissection increases the risk of arterial injury, bleeding from the venous plexus surrounding the artery, injury to radicular arteries, and injury to the sympathetic nerves resulting in a H o m e r ' s syndrome. It is important that tension at the anastomotic site be avoided. Anastomosis too near the carotid bifurcation is also undesirable. A saphenous vein graft requires another procedure to harvest the vein, and an adequate vein may not be obtainable for a variety of reasons. Expanded PTFE is a material readily available for grafting and is technically easy to work with. Clinical experience with PTFE derives from its use in peripheral vascular surgery and coronary bypass operations. Experimental work with microarterial anastomoses has also been performed. 1,5.7,12.19.20 Expanded PTFE is composed of PTFE nodes connected by thin fibers of the same material, producing a mesh with 30-~ diameter pores. The grafts are externally strengthened by a fine lattice of PTFE. Histological examination shows that the graft allows the ingrowth of platelets, capillary formation, and the establishment of a neointima. 5'~9 Soon after placement, the graft is covered by a fibrin network, which increases and is then joined by platelet cells. A continuous neointima from the host vessel is progressively formed over the fibrin layer. ~9 Formation of neointima in the graft is important for maintaining a physiological surface in contact with the blood. The possibility of hypertrophy of the intima and resultant stenosis or occlusion must be considered. Watanabe ~9 used grafts 20 m m in length with an inside diameter of 1.5 m m , and showed that a neointima was present at 14 days; however, it took 90 days for the entire graft to be covered. 2' reported five patients with PTFE grafts, of which four were patent 3 to 6 months postoperatively. Sapsford, et al., ~6 reported a total of 27 grafts used in 16 patients. The angiographic follow-up monitoring varied, but six of nine grafts were patent 12 to 29 months postoperatively.
In our series of eight patients, five are alive and asymptomatic. One graft occlusion occurred acutely with a fatal outcome. The other two deaths were the result of myocardial infarctions, one early and one late. Both patients had patent grafts angiographically. The average duration of radiographic follow-up studies in the five survivors (angiograms or IV-DSA in all five and ultrasound study in one) is 60 months after graft placement, and all grafts are patent without evidence of progressive stenosis.
